Article tools
Author information

Research Article

Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.

M A Becker

Published February, 1976

In the majority of patients with gout and excessive uric acid production, underlying enzyme abnormalities have not been identified. In the present study, measurement of both the rate of generation and concentration of phosphoribosylpyrophosphate (PP-ribose-P) and the concentration of ribose-5-phosphate in cultured cells were undertaken to establish a classification of purine overproducers to direct study of additional enzyme defects. Fibroblasts were cultured from 24 individuals assigned to 4 groups: group 1, 5 normal controls; group 2, 5 patients with gout and normal dialy urinary uric acid excretion (gouty controls); group 3, 7 patients with well-defined enzyme abnormalities and excessive urinary acid excretion (4 with hypoxanthine-guanine phosphoribosyltransferase deficiency and 3 with excessive PP-ribose-P synthetase activity); and group 4, 7 patients with gout and excessive uric acid excretion but without grossly abnormal activities of the above enzymes in erythrocyte lysates. In all 14 fibroblast strains from patients showing excessive production of uric acid (groups 3 and 4), rates of purine synthesis de novo and PP-ribose-P concentrations exceeded values for cells from control groups. Cells from group 3 patients with hypoxanthine-guanine phosphoribosyltransferase deficiency showed normal PP-ribose-P generation, while those with excessive PP-ribose-P synthetase activity demonstrated increased generation of this regulatory substrate. All strains from group 3 patients had normal ribose-5-phosphate concentrations. Five cell strains from group 4 patients showed one of the two patterns of abnormalities in these measurements seen in strains from group 3 patients: two resembled hypoxanthine-guanine phosphoribosyltransferase-deficient cells, and three resembled cells with excessive PP-ribose-P synthetase activity. Analyses of erythrocyte enzyme preparations from two of these patients in group 4 have led to identification of a kinetic variant of each enzyme as predicted from the foregoing patterns. Two additional group 4 cell lines that showed increased ribose-5-phosphate concentrations in addition to increased PP-ribose-P concentrations and generation were classified in a separate subgroup, since in the individuals excessive purine synthesis appeared to result from increases ribose-5-phosphate concentration, leading to increased availability of PP-ribose-P. No abnormality in either hypoxanthine-guanine phosphoribosyltransferase or PP-ribose-P synthetase has been found in erythrocyte preparations from one patient so classified.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Articles that cite
this article:

Prognostic implications of renal hypertrophy in diabetes mellitus
Kenneth S. Kleinman, Leon G. Fine
Diabetes Metab Rev 4(2):179. [CrossRef]

Biochemical genetics of Chinese hamster cell mutants with deviant purine metabolism: Isolation, selection, and characterization of a mutant lacking hypoxanthine-guanine phosphoribosyltransferase activity by nutritional means
David Patterson, Carol Jones
Somat Cell Mol Genet 2(5):429. [CrossRef]

Clinical and biochemical aspects of uric acid overproduction
J. García Puig, F. Antón Mateos
Pharm World Sci 16(2):40. [CrossRef]

Molecular Analysis of Chromosome 21 Using Somatic Cell Hybrids
DAVID Patterson, MARGARET van Keuren, HARRY Drabkin, PAUL Watkins, JAMES Gusellay, CHARLES Scoggin
Ann N Y Acad Sci 450(1 molecular org):109. [CrossRef]

Phosphoribosylpyrophosphate synthetase superactivity: A study of five patients with catalytic defects in the enzyme
Michael A. Becker, Michele J. Losman, Alan L. Rosenberg, Ira Mehlman, Dennis J. Levinson, Edward W. Holmes
Arthritis Rheum 29(7):880. [CrossRef]